Cargando…

Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept

Detalles Bibliográficos
Autores principales: Tresh, Amani, Smith, Victoria H., Parslew, Richard A.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470718/
https://www.ncbi.nlm.nih.gov/pubmed/23071483
http://dx.doi.org/10.3402/ljm.v7i0.19139
_version_ 1782246312963473408
author Tresh, Amani
Smith, Victoria H.
Parslew, Richard A.G.
author_facet Tresh, Amani
Smith, Victoria H.
Parslew, Richard A.G.
author_sort Tresh, Amani
collection PubMed
description
format Online
Article
Text
id pubmed-3470718
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-34707182012-10-15 Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept Tresh, Amani Smith, Victoria H. Parslew, Richard A.G. Libyan J Med Letter to the Editor Co-Action Publishing 2012-10-11 /pmc/articles/PMC3470718/ /pubmed/23071483 http://dx.doi.org/10.3402/ljm.v7i0.19139 Text en © 2012 Amani Tresh et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Tresh, Amani
Smith, Victoria H.
Parslew, Richard A.G.
Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept
title Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept
title_full Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept
title_fullStr Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept
title_full_unstemmed Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept
title_short Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept
title_sort behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470718/
https://www.ncbi.nlm.nih.gov/pubmed/23071483
http://dx.doi.org/10.3402/ljm.v7i0.19139
work_keys_str_mv AT treshamani behcetssyndrometreatedwithinfliximabwhichcausedapalmoplantarpustulosissubsequentlymaintainedonlowdoseetanercept
AT smithvictoriah behcetssyndrometreatedwithinfliximabwhichcausedapalmoplantarpustulosissubsequentlymaintainedonlowdoseetanercept
AT parslewrichardag behcetssyndrometreatedwithinfliximabwhichcausedapalmoplantarpustulosissubsequentlymaintainedonlowdoseetanercept